SAB Biotherapeutics plans participation in four investor conferences
SABS•SAB Biotherapeutics will attend four investor conferences. CEO Samuel J. Reich will lead fireside chats at three events, with one-on-one meetings scheduled at the fourth.
1. Conference schedule
CEO Samuel J. Reich will hold fireside chats at the Jefferies Global Healthcare Conference on November 16, the UBS Global Biopharma Conference on November 17, and the 9th Annual Evercore Healthcare Conference on December 1. SAB Biotherapeutics will also hold one-on-one meetings at the Citi Global Healthcare Conference on December 2.
